Aarti Drugs Limited has informed the Exchange about Schedule of meet
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs has informed the stock exchanges about an upcoming analyst and institutional investor meeting scheduled for May 29, 2025, from 10 am to 1 pm. The meetings will be held in person as part of the B & K Conference. The company has clarified that discussions during these meetings will be limited to publicly available information. The disclosure has been made under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015.
This is a routine compliance disclosure with no direct impact on the stock price. It indicates the company is actively engaging with the investor community, which is standard practice and supports transparency.